Multaq (dronedarone) Liver Failure Attorneys
Multaq (dronedarone) is a prescription drug prescribed to patients with an abnormal heart rythym (atrial flutter or atrial fibrilation). In January of 2011, after reports of Multaq (dronedarone) patients with liver failure requiring liver transplants, the U.S. Food & Drug Administration (FDA) announced the label for Multaq (dronedarone) will be updated to warn of the risk of severe liver damage and liver failure.
If you or a loved one suffered liver damage after taking Multaq (dronedarone), you should consult with experienced product liability attorneys right away to preserve your legal rights. Our experienced Multaq lawyers are holding the drug’s manufacturer, Sanofi-Aventis, accountable by filing Multaq liver failure lawsuits on behalf of Multaq users who have suffered from Multaq Liver Failure, Multaq Liver Damage, or required a liver transplant after taking Multaq (dronedarone). Our product liability lawyers represent every Multaq liver damage lawsuit client on a contingent fee basis, meaning there are absolutely no legal fees or costs unless you recover money.
Multaq Linked to Liver Failure Requiring Liver Transplant
In two reported cases of Multaq liver failure, requiring liver transplantation both victims were women, approximately seventy (70) years-old, and had had normal liver serum enzymes before taking Multaq (dronedarone) for atrial fibrilation (abnormal heart rhythm). Both victims suffered severe liver failure within months of taking Multaq for atrial fibrillation problems and doctors found extensive cellular death in the liver of both patients. In both cases doctors ruled out other possible causes of liver failure.
Multaq Liver Damage and Liver Failure Symptoms
The FDA recommends that doctors warn their patients to report any symptoms or signs of liver damage, liver toxicity or liver failure to a healthcare professional.
Symptoms of liver damage and liver failure while taking Multaq (dronedarone) include:
- Anorexia while taking Multaq
- Nausea or vomiting while taking Multaq
- Fever or fatigue after taking Multaq
- Jaundice while taking Multaq
- Dark urine after taking Multaq
- Itching or itchy feeling while taking Multaq
According to the FDA, doctors should monitor a patient’s serum liver enzymes, particularly during the first six (6) months of Multaq treatment. If a doctor suspects liver damage, liver failure or another hepatic injury, the FDA recommends the doctor take the patient off of Multaq and test the patient’s serum liver enzymes and bilirubin levels. The FDA also warned doctors not to reintroduce Multaq to patients who have suffered unexplained liver damage.
Multaq (Dronedarone) Liver Damage Attorneys
Our Multaq (dronedarone) lawyers are helping victims who suffered Multaq (dronedarone) liver failure, Multaq (dronedarone) liver damage or received a liver transplant after taking Multaq (dronedarone). Please call us right away to speak with dangerous drug attorneys who specialize in defective pharmaceutical litigation and dangerous drug recall lawsuits. We can help you and your family to get the justice and compensation you need and deserve.